vaccine- Page 2

First patient in UK given ‘vaccine’ for cancer in pioneering clinical research trial

February 4, 2022

British Reporter — A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning – in a clinical research trial which may help bring further ground-breaking treatments for the disease.

Willing but unable to get COVID shot

British Reporter — Study of racial, ethnic disparities in vaccine rates suggests

by British Reporter

February 1, 2022

2 mins read

Covid-19 Vaccine Protection Wanes After Three Months, Study Suggests

British Reporter — The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine

by British Reporter

December 27, 2021

2 mins read

COVID-19 vaccine volunteers share their stories, one year later

British Reporter — Within the space of one momentous week in December

by British Reporter

December 18, 2021

3 mins read

Economic

Vaccine Inequity Undermining Global Economic Recovery

British Reporter — New Global Dashboard on COVID-19 Vaccine Equity finds low-income countries would add $38 billion to their GDP forecast for 2021 if they had the same vaccination rate as high-income countries. Global economic recovery at risk if vaccines are not

by British Reporter

July 22, 2021

2 mins read

Coronavirus

A COVID vaccine for kids

More than half a year has passed since the first vaccine for COVID-19 was given emergency authorization, and almost half the United States has protection against the SARS-CoV-2 virus as a result. Yet children under the age of 12, for whom the

by British Reporter

July 22, 2021

8 mins read

Health&Beauty

Vaccine lotteries and beyond: What motivates healthy behaviors

British Reporter — Over a decade ago, as a primary care physician with a Ph.D. in economics, Kevin Volpp, director of the Center for Health Incentives and Behavioral Economics (CHIBE) in the Perelman School of Medicine, noticed an interesting phenomenon in health

by British Reporter

July 5, 2021

1 min read

Coronavirus

World Bank Financing for COVID-19 Vaccine Rollout Reaches $2 Billion

British Reporter — The World Bank announced today that it has reached $2 billion in approved financing for the purchase and distribution of COVID-19 vaccines for 17 developing countries. This financing is part of the $12 billion envelope over 24 months for

by British Reporter

May 22, 2021

2 mins read

Coronavirus

J&J COVID-19 vaccine pause ends

British Reporter — On Friday, April 23, the Advisory Committee on Immunization Practices (ACIP), an independent immunization advisory group for the Centers for Disease Control and Prevention, voted to resume distribution of the Johnson & Johnson (J&J) COVID-19 vaccine after a 10-day

by British Reporter

April 27, 2021

2 mins read

Coronavirus

World Bank Financing for COVID-19 Vaccine Rollout Reaches $2 Billion

British Reporter — World Bank announced today that it has reached $2 billion in approved financing for the purchase and distribution of COVID-19 vaccines for 17 developing countries. This financing is part of the $12 billion envelope over 24 months for developing

by British Reporter

April 20, 2021

2 mins read

Coronavirus·Guest articles

Study suggests those who had COVID-19 may only need one vaccine dose

British Reporter — People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in

by British Reporter

April 17, 2021

1 min read

Coronavirus

Human Trials Begin for a Low-Cost COVID-19 Vaccine

British Reporter-– In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent

by British Reporter

April 5, 2021

3 mins read

UK local news

Janssen’s coronavirus vaccine trials begin across the UK involving 6,000 volunteers

The FINANCIAL — Global pharmaceutical company Janssen will begin clinical trials of its potential vaccine in the UK from today (Monday 16 November), involving 6,000 volunteers across the country. The Janssen Pharmaceutical Companies, part of Johnson & Johnson, is the latest study

by The FINANCIAL

November 16, 2020

3 mins read

Coronavirus

Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

The FINANCIAL — Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity. Based on the positive

by The FINANCIAL

November 13, 2020

1 min read